Skip to content
10-Q

Quarterly Report

Arena Pharmaceuticals, Inc.

0001080709-21-000038

← back to feed
Filed
Nov 4, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · Oct 28, 2021 61.33M sh
Shares Diluted Q3 2021 · Sep 30, 2021 61.14M sh
Shares Diluted Q3 2021 · Sep 30, 2021 60.57M sh
Shares Diluted Q3 2021 · Sep 30, 2020 57.78M sh
Shares Diluted Q3 2021 · Sep 30, 2020 53.61M sh
Capex Q3 2021 · Sep 30, 2021 $455K
Capex Q3 2021 · Sep 30, 2020 $684K
Operating Cash Flow Q3 2021 · Sep 30, 2021 −$331.52M
Operating Cash Flow Q3 2021 · Sep 30, 2020 −$246.71M
Cash And Equivalents Q3 2021 · Sep 30, 2021 $386.65M
Cash And Equivalents Q3 2021 · Dec 31, 2020 $219.54M
Stockholders Equity Q3 2021 · Sep 30, 2021 $800.72M
Stockholders Equity Q3 2021 · Jun 30, 2021 $971.08M
Stockholders Equity Q3 2021 · Mar 31, 2021 $1.09B
Stockholders Equity Q3 2021 · Dec 31, 2020 $1.08B
Stockholders Equity Q3 2021 · Sep 30, 2020 $1.17B
Stockholders Equity Q3 2021 · Jun 30, 2020 $1.24B
Stockholders Equity Q3 2021 · Mar 31, 2020 $988.49M
Stockholders Equity Q3 2021 · Dec 31, 2019 $1.07B
Current Liabilities Q3 2021 · Sep 30, 2021 $53.36M
Current Liabilities Q3 2021 · Dec 31, 2020 $58.08M
Current Assets Q3 2021 · Sep 30, 2021 $790.92M
Current Assets Q3 2021 · Dec 31, 2020 $1.14B
Total Assets Q3 2021 · Sep 30, 2021 $901.03M
Total Assets Q3 2021 · Dec 31, 2020 $1.19B
Eps Diluted Q3 2021 · Sep 30, 2021 −$3.21
Eps Diluted Q3 2021 · Sep 30, 2021 −$7.61
Eps Diluted Q3 2021 · Sep 30, 2020 −$1.69
Eps Diluted Q3 2021 · Sep 30, 2020 −$5.27
Eps Basic Q3 2021 · Sep 30, 2021 −$3.21
Eps Basic Q3 2021 · Sep 30, 2021 −$7.61
Eps Basic Q3 2021 · Sep 30, 2020 −$1.69
Eps Basic Q3 2021 · Sep 30, 2020 −$5.27
Sga Expense Q3 2021 · Sep 30, 2021 $30.31M
Sga Expense Q3 2021 · Sep 30, 2021 $91.7M
Sga Expense Q3 2021 · Sep 30, 2020 $19M
Sga Expense Q3 2021 · Sep 30, 2020 $68.32M
Net Income Q3 2021 · Sep 30, 2021 −$196.31M
Net Income Q3 2021 · Sep 30, 2021 −$460.82M
Net Income Q3 2021 · Jun 30, 2021 −$146.1M
Net Income Q3 2021 · Mar 31, 2021 −$118.42M
Net Income Q3 2021 · Sep 30, 2020 −$97.44M
Net Income Q3 2021 · Sep 30, 2020 −$282.57M
Net Income Q3 2021 · Jun 30, 2020 −$84.93M
Net Income Q3 2021 · Mar 31, 2020 −$100.21M
Operating Income Q3 2021 · Sep 30, 2021 −$194.49M
Operating Income Q3 2021 · Sep 30, 2021 −$470.87M
Operating Income Q3 2021 · Sep 30, 2020 −$98.8M
Operating Income Q3 2021 · Sep 30, 2020 −$291.34M
Revenue Q3 2021 · Sep 30, 2021 $0
Revenue Q3 2021 · Sep 30, 2021 $0
Revenue Q3 2021 · Sep 30, 2020 $20K
Revenue Q3 2021 · Sep 30, 2020 $282K